» Articles » PMID: 35417639

Cancer-Associated Hypercalcemia

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2022 Apr 13
PMID 35417639
Authors
Affiliations
Soon will be listed here.
Citing Articles

Prevalence and Associated Factors of Hypercalcemia of Malignancy Among Advanced Cancer Patients Attending Palliative Care Unit of a Tertiary Care Hospital in Bangladesh.

Rouf R, Bhuiyan A, Alam A, Chowdhury M Cancer Rep (Hoboken). 2025; 8(3):e70157.

PMID: 40067052 PMC: 11894818. DOI: 10.1002/cnr2.70157.


Parathyroid hormone-related protein levels and treatment outcomes in hypercalcemia of malignancy: a retrospective cohort study.

Kato K, Nakashima A, Kimura A, Maruyama Y, Ohkido I, Miyazaki Y JBMR Plus. 2025; 9(3):ziae178.

PMID: 39925622 PMC: 11807284. DOI: 10.1093/jbmrpl/ziae178.


Successful Treatment of Methotrexate-associated Lymphoproliferative Disorder with the Pola-R-CHP Regimen.

Seki H, Morita K, Yamazaki S, Kurokawa M Intern Med. 2025; 64(1):123-127.

PMID: 39757000 PMC: 11781930. DOI: 10.2169/internalmedicine.3634-24.


Case report: Ectopic production of intact parathyroid hormone (iPTH) by malignoma mimicking primary hyperparathyroidism.

Wendt R, Heller M, Hartwig D, Ullmann S, Bisanz H, Geister D Front Oncol. 2024; 14:1422131.

PMID: 39703837 PMC: 11655464. DOI: 10.3389/fonc.2024.1422131.


The identification and correction of pseudohypercalcemia.

Yu T, Li X, Huang B, Gu J, Liu J, Chen M Front Oncol. 2024; 14:1441851.

PMID: 39544294 PMC: 11560909. DOI: 10.3389/fonc.2024.1441851.